IL-17–Mediated Downregulation of miR-101 Facilitates the Expression of EZH2 to Promote Epidermal Hyperplasia in Psoriasis

Page view(s)
201
Checked on Jun 16, 2024
IL-17–Mediated Downregulation of miR-101 Facilitates the Expression of EZH2 to Promote Epidermal Hyperplasia in Psoriasis
Title:
IL-17–Mediated Downregulation of miR-101 Facilitates the Expression of EZH2 to Promote Epidermal Hyperplasia in Psoriasis
Journal Title:
Journal of Investigative Dermatology
Publication Date:
12 August 2023
Citation:
Quah, S., Sundaram, G. M., Subramanian, G., Vaz, C., Tan, J. S. L., Kabir, R. F., Ong, J. M. R., Oon, H. H., Theng, C., & Sampath, P. (2024). IL-17–Mediated Downregulation of miR-101 Facilitates the Expression of EZH2 to Promote Epidermal Hyperplasia in Psoriasis. Journal of Investigative Dermatology, 144(2), 403-407.e7. https://doi.org/10.1016/j.jid.2023.07.013
Abstract:
This is a letter to editor format and no abstract is required.
License type:
Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
Funding Info:
This research / project is supported by the Agency for Science, Technology and Research (A*STAR)- National Healthcare Group (NHG) - Skin Innovation Grant
Grant Reference no. : NA

This research / project is supported by the Biomedical Research Council (BMRC) - Central Research Fund (CRF)
Grant Reference no. : NA
Description:
Datasets related to this article can be found at https://www.ncbi.nlm.nih. gov/geo/query/acc.cgi?acc1⁄4GSE220586 hosted at National Center for Bio- technology Information’s Gene Expres- sion Omnibus with Gene Expression Omnibus Series accession number GSE220586.
ISSN:
0022-202X
Collections: